Safinamide Improves Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safinamide Improves Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study
Authors
Keywords
-
Journal
Brain Sciences
Volume 11, Issue 3, Pages 316
Publisher
MDPI AG
Online
2021-03-03
DOI
10.3390/brainsci11030316
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The effect of monoamine oxidase-B inhibitors on the alleviation of depressive symptoms in Parkinson’s disease: meta-analysis of randomized controlled trials
- (2021) Yao Hsien Huang et al. Therapeutic Advances in Psychopharmacology
- SURINPARK: Safinamide for Urinary Symptoms in Parkinson’s Disease
- (2021) Ana Gómez-López et al. Brain Sciences
- Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease
- (2020) Clarissa A. Pisanò et al. NEUROPHARMACOLOGY
- Effects of safinamide on pain in Parkinson’s disease with motor fluctuations: an exploratory study
- (2020) Christian Geroin et al. JOURNAL OF NEURAL TRANSMISSION
- Impact of COVID ‐19 Pandemic on Parkinson´s Disease: A Cross‐sectional Survey of 568 Spanish Patients
- (2020) D. Santos García et al. MOVEMENT DISORDERS
- Efficacy and safety of safinamide as an add-on therapy to L-DOPA for patients with Parkinson's disease: A randomized, double-blind, placebo-controlled, phase II/III study
- (2020) Nobutaka Hattori et al. PARKINSONISM & RELATED DISORDERS
- Safinamide improves executive functions in fluctuating Parkinson’s disease patients: an exploratory study
- (2020) Domiziana Rinaldi et al. JOURNAL OF NEURAL TRANSMISSION
- Long-term safety and efficacy of safinamide as add-on therapy in levodopa-treated Japanese patients with Parkinson's disease with wearing-off: Results of an open-label study
- (2020) Yoshio Tsuboi et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial
- (2020) Giovanni Abbruzzese et al. Journal of Parkinsons Disease
- Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort
- (2019) García D. Santos et al. PARKINSONISM & RELATED DISORDERS
- Long-Term Efficacy of Safinamide on Symptoms Severity and Quality of Life in Fluctuating Parkinson’s Disease Patients
- (2019) Carlo Cattaneo et al. Journal of Parkinsons Disease
- Safinamide in Clinical Practice: A Spanish Multicenter Cohort Study
- (2019) Gloria Martí-Andrés et al. Brain Sciences
- Long-term Efficacy of Safinamide on Parkinson’s Disease Chronic Pain
- (2018) Carlo Cattaneo et al. ADVANCES IN THERAPY
- Safinamide effect on sleep disturbances and daytime sleepiness in motor fluctuating Parkinson's disease patients: A validated questionnaires-controlled study
- (2018) Claudio Liguori et al. PARKINSONISM & RELATED DISORDERS
- Effective treatment of restless legs syndrome by safinamide in Parkinson's disease patients
- (2018) Claudio Liguori et al. SLEEP MEDICINE
- Wirksamkeit und Sicherheit von Safinamid als Zusatztherapie zu Levodopa bei Parkinson-Patienten: eine nicht-interventionelle Beobachtungsstudie
- (2018) Wolfgang H. Jost et al. FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
- Efficacy of safinamide on non-motor symptoms in a cohort of patients affected by idiopathic Parkinson’s disease
- (2018) Maria Laura Ester Bianchi et al. NEUROLOGICAL SCIENCES
- Comprehensive grading of Parkinson’s disease using motor and non-motor assessments: addressing a key unmet need
- (2017) Pablo Martinez-Martin et al. Expert Review of Neurotherapeutics
- Safinamide Differentially Modulates In Vivo Glutamate and GABA Release in the Rat Hippocampus and Basal Ganglia
- (2017) Michele Morari et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Effects of Safinamide on Pain in Fluctuating Parkinson’s Disease Patients: A Post-Hoc Analysis
- (2017) Carlo Cattaneo et al. Journal of Parkinsons Disease
- Long-Term Effects of Safinamide on Mood Fluctuations in Parkinson’s Disease
- (2017) Carlo Cattaneo et al. Journal of Parkinsons Disease
- Comprehensive grading of Parkinson’s disease using motor and non-motor assessments: addressing a key unmet need
- (2017) Pablo Martinez-Martin et al. Expert Review of Neurotherapeutics
- Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations
- (2017) Anthony H. V. Schapira et al. JAMA Neurology
- Patterns and predictors of freezing of gait improvement following rasagiline therapy: A pilot study
- (2016) Fariborz Rahimi et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- The safety and efficacy of safinamide mesylate for the treatment of Parkinson’s disease
- (2016) Santiago Perez-Lloret et al. Expert Review of Neurotherapeutics
- Adjuvant therapies for Parkinson’s disease: critical evaluation of safinamide
- (2016) Fabrizio Stocchi et al. Drug Design Development and Therapy
- Safinamide as Add-On Therapy to Levodopa in Mid- to Late-Stage Parkinson’s Disease Fluctuating Patients: Post hoc Analysesof Studies 016 and SETTLE
- (2016) Carlo Cattaneo et al. Journal of Parkinsons Disease
- The safety and efficacy of safinamide mesylate for the treatment of Parkinson’s disease
- (2016) Santiago Perez-Lloret et al. Expert Review of Neurotherapeutics
- Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non-motor symptoms - results of a double-blind, randomized, placebo-controlled trial
- (2015) A. Antonini et al. EUROPEAN JOURNAL OF NEUROLOGY
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation
- (2015) K. Ray Chaudhuri et al. MOVEMENT DISORDERS
- Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease
- (2014) Rupam Borgohain et al. MOVEMENT DISORDERS
- Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics
- (2014) Peter A. LeWitt MOVEMENT DISORDERS
- Safinamide for the treatment of Parkinson’s disease
- (2014) Rukmini Mridula Kandadai et al. Expert Review of Clinical Pharmacology
- Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease
- (2013) Diego Santos-García et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations
- (2013) Rupam Borgohain et al. MOVEMENT DISORDERS
- Pain in Parkinson disease: A review of the literature
- (2012) Ayla Fil et al. PARKINSONISM & RELATED DISORDERS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started